礼来制药 LLY 深 沪
等待开盘 06-26 09:30:00 美东时间
1127.845
+10.115
+0.90%
华盛通- 最 高1145.43
- 今 开1126.99
- 成交量 216.85万股
- 最 低 1079.22
- 昨 收 1117.73
- 总市值 10.71亿
- 52周最高 1182.73
- 市盈率 静 184.22
- 换手率 228.27%
- 52周最低 623.789
- 委 比 49.40%
- 总股本 0.01亿
- 历史最高 1182.73
- 量 比 0.73
- 振 幅 5.92%
- 历史最低 -1.46
- 每 手 1
- 风险率 137.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success
ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concurrent share purchase.
06-25 21:56
Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact
Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.
06-24 23:11
刚刚，上海Biotech达成129亿元合作
（来源：动脉新医药） 6月24日，和誉医药宣布已与礼来签署战略研究合作及授权协议。根据该协议，双方将围绕多个疾病靶点开展创新药研发合作，共同推进具有全球潜力的新...
06-24 13:53
Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and specialty grocers win.
06-22 19:15
Eli Lilly Eyes Label Expansion For Leukemia Drug
Eli Lilly's Phase 3 BRUIN CLL-322 study showed Jaypirca combination therapy cut progression or death risk by 45% in CLL/SLL.
06-16 01:43
Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages
Eli Lilly reports Foundayo delivered significant weight loss across menopausal stages, with up to 14.4% reductions at 72 weeks.
06-08 22:03
Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs
Novo Nordisk reported positive diabetes and weight-loss data, advanced zenagamtide plans, and topped 3 million Wegovy pill prescriptions.
06-08 20:55
WW International, Affiliated Medical Groups Now Accessible Through Eli Lilly's LillyDirect
WW International, Inc. (NASDAQ: WW) and its affiliated medical groups ("Weight Watchers"), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform,
06-04 20:02
Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations
Eli Lilly signs drug development deals with Hanmi and Haisco as Retevmo Phase 3 data show an 83% cut in recurrence risk.
06-02 01:19
Eli Lilly to Buy Curevo for Up to $1.5B, LimmaTech for $780M, Vaccine Company for $1.55B
Eli Lilly and Company (NYSE: LLY) today announced agreements to acquire three companies, Curevo Inc. (Curevo), LimmaTech Biologics AG (LimmaTech Biologics), and Vaccine Company, Inc. (Vaccine Company), that expand
05-26 18:50
公司简介
公司名称
|
礼来制药
|
行业分类
|
制药
|
业务描述
|
美国礼来制药（Eli Lilly and Company）于1876年5月10日成立，是一家全球性的以研发为基础的医药公司，至今已有139年的历史。
公司总部设在位于美国印地安纳州的印第安纳波里斯市，全球员工约41000名。礼来的临床试验研究遍布全球55个国家，在全球6个国家设有研发中心，工厂遍布13个国家，产品行销于全球120个国家。
礼来于1918年来到中国，将其第一个海外代表处设在上海，从而迈出了全球化的第一步。虽然几经风雨，礼来在1993年重新回到中国，在全国数十个城市建立了办事机构，在中国拥有员工近四千人，目前公司业务已经深入到中国近四百个城市。
|
Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success
ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concurrent share purchase.
06-25 21:56
Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact
Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.
06-24 23:11
刚刚，上海Biotech达成129亿元合作
（来源：动脉新医药） 6月24日，和誉医药宣布已与礼来签署战略研究合作及授权协议。根据该协议，双方将围绕多个疾病靶点开展创新药研发合作，共同推进具有全球潜力的新...
06-24 13:53
Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and specialty grocers win.
06-22 19:15
Eli Lilly Eyes Label Expansion For Leukemia Drug
Eli Lilly's Phase 3 BRUIN CLL-322 study showed Jaypirca combination therapy cut progression or death risk by 45% in CLL/SLL.
06-16 01:43
Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages
Eli Lilly reports Foundayo delivered significant weight loss across menopausal stages, with up to 14.4% reductions at 72 weeks.
06-08 22:03
Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs
Novo Nordisk reported positive diabetes and weight-loss data, advanced zenagamtide plans, and topped 3 million Wegovy pill prescriptions.
06-08 20:55
WW International, Affiliated Medical Groups Now Accessible Through Eli Lilly's LillyDirect
WW International, Inc. (NASDAQ: WW) and its affiliated medical groups ("Weight Watchers"), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform,
06-04 20:02
Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations
Eli Lilly signs drug development deals with Hanmi and Haisco as Retevmo Phase 3 data show an 83% cut in recurrence risk.
06-02 01:19
Eli Lilly to Buy Curevo for Up to $1.5B, LimmaTech for $780M, Vaccine Company for $1.55B
Eli Lilly and Company (NYSE: LLY) today announced agreements to acquire three companies, Curevo Inc. (Curevo), LimmaTech Biologics AG (LimmaTech Biologics), and Vaccine Company, Inc. (Vaccine Company), that expand
05-26 18:50
派息除权日
|
每股总股息
| 派息日期 |
2024-05-15
|
1.30
|
2024-06-10
|
2024-02-14
|
1.30
|
2024-03-08
|
2023-11-14
|
1.13
|
2023-12-08
|
2023-08-14
|
1.13
|
2023-09-08
|
2023-05-12
|
1.13
|
2023-06-09
|
2023-02-14
|
1.13
|
2023-03-10
|
2022-11-14
|
0.98
|
2022-12-09
|
2022-08-12
|
0.98
|
2022-09-09
|
2022-05-13
|
0.98
|
2022-06-10
|
2022-02-14
|
0.98
|
2022-03-10
|
2021-11-12
|
0.85
|
2021-12-10
|
2021-08-12
|
0.85
|
2021-09-10
|
2021-05-13
|
0.85
|
2021-06-10
|
2021-02-11
|
0.85
|
2021-03-10
|
2020-11-12
|
0.74
|
2020-12-10
|
2020-08-13
|
0.74
|
2020-09-10
|
2020-05-14
|
0.74
|
2020-06-10
|
2020-02-13
|
0.74
|
2020-03-10
|
2019-11-14
|
0.64
|
2019-12-10
|
2019-08-14
|
0.64
|
2019-09-10
|
2019-05-16
|
0.64
|
2019-06-10
|
2019-02-14
|
0.64
|
2019-03-08
|
2018-11-14
|
0.56
|
2018-12-10
|
2018-08-14
|
0.56
|
2018-09-10
|
2018-05-16
|
0.56
|
2018-06-08
|
2018-02-14
|
0.56
|
2018-03-09
|
2017-11-14
|
0.52
|
2017-12-08
|
2017-08-11
|
0.52
|
2017-09-08
|
2017-05-11
|
0.52
|
2017-06-09
|
2017-02-13
|
0.52
|
2017-03-10
|
2016-11-10
|
0.51
|
2016-12-09
|
2016-08-11
|
0.51
|
2016-09-09
|
2016-05-11
|
0.51
|
2016-06-10
|
2016-02-10
|
0.51
|
2016-03-10
|
2015-11-10
|
0.50
|
2015-12-10
|
2015-08-12
|
0.50
|
2015-09-10
|
2015-05-14
|
0.50
|
2015-06-10
|
2015-02-11
|
0.50
|
2015-03-10
|
2014-11-12
|
0.49
|
2014-12-10
|
2014-08-13
|
0.49
|
2014-09-10
|
2014-05-13
|
0.49
|
2014-06-10
|
2014-02-12
|
0.49
|
2014-03-10
|
2013-11-13
|
0.49
|
2013-12-10
|
2013-08-13
|
0.49
|
2013-09-10
|
2013-05-14
|
0.49
|
2013-06-10
|
2013-02-13
|
0.49
|
2013-03-08
|
2012-11-13
|
0.49
|
2012-12-10
|
2012-08-13
|
0.49
|
2012-09-10
|
2012-05-11
|
0.49
|
2012-06-08
|
2012-02-13
|
0.49
|
2012-03-09
|
2011-11-10
|
0.49
|
2011-12-09
|
2011-08-11
|
0.49
|
2011-09-09
|
2011-05-11
|
0.49
|
2011-06-10
|
2011-02-11
|
0.49
|
2011-03-10
|
2010-11-10
|
0.49
|
2010-12-10
|
2010-08-11
|
0.49
|
2010-09-10
|
2010-05-12
|
0.49
|
2010-06-10
|
2010-02-10
|
0.49
|
2010-03-10
|
2009-11-10
|
0.49
|
2009-12-10
|
2009-08-12
|
0.49
|
2009-09-10
|
2009-05-13
|
0.49
|
2009-06-10
|
2009-02-11
|
0.49
|
2009-03-10
|
2008-11-12
|
0.47
|
2008-12-10
|
2008-08-13
|
0.47
|
2008-09-10
|
2008-05-13
|
0.47
|
2008-06-10
|
2008-02-13
|
0.47
|
2008-03-10
|
2007-11-13
|
0.43
|
2007-12-10
|
2007-08-13
|
0.43
|
2007-09-10
|
2007-05-11
|
0.43
|
2007-06-08
|
2007-02-13
|
0.43
|
2007-03-09
|
2006-11-13
|
0.40
|
2006-12-08
|
2006-08-11
|
0.40
|
2006-09-08
|
2006-05-11
|
0.40
|
2006-06-09
|
2006-02-13
|
0.40
|
2006-03-10
|
2005-11-10
|
0.38
|
2005-12-09
|
2005-08-11
|
0.38
|
2005-09-09
|
2005-05-11
|
0.38
|
2005-06-10
|
2005-02-11
|
0.38
|
2005-03-10
|
2004-11-10
|
0.35
|
2004-12-10
|
2004-08-11
|
0.35
|
2004-09-10
|
2004-05-12
|
0.35
|
2004-06-10
|
2004-02-11
|
0.35
|
2004-03-10
|
2003-11-12
|
0.34
|
2003-12-10
|
2003-08-13
|
0.34
|
2003-09-10
|
2003-05-13
|
0.34
|
2003-06-10
|
2003-02-12
|
0.34
|
2003-03-10
|
2002-11-13
|
0.31
|
2002-12-10
|
2002-08-13
|
0.31
|
2002-09-10
|
2002-05-13
|
0.31
|
2002-06-10
|
2002-02-13
|
0.31
|
2002-03-08
|
2001-11-13
|
0.28
|
2001-12-10
|
2001-08-13
|
0.28
|
2001-09-10
|
2001-05-11
|
0.28
|
2001-06-11
|
2001-02-13
|
0.28
|
2001-03-09
|
2000-11-13
|
0.26
|
2000-12-11
|
2000-08-11
|
0.26
|
2000-09-11
|
2000-05-11
|
0.26
|
2000-06-09
|
2000-02-11
|
0.26
|
2000-03-10
|
1999-11-10
|
0.23
|
1999-12-10
|
1999-08-11
|
0.23
|
1999-09-10
|
1999-05-12
|
0.23
|
1999-06-10
|
1999-02-10
|
0.23
|
1999-03-10
|
1998-11-10
|
0.20
|
1998-12-10
|
1998-08-12
|
0.20
|
1998-09-10
|
1998-05-13
|
0.20
|
1998-06-10
|
1998-02-11
|
0.20
|
1998-03-10
|
1997-11-12
|
0.20
|
1997-12-10
|
1997-08-13
|
0.36
|
1997-09-10
|
1997-05-13
|
0.36
|
1997-06-10
|
1997-02-12
|
0.36
|
1997-03-10
|
1996-11-13
|
0.34
|
1996-12-10
|
1996-08-13
|
0.34
|
1996-09-10
|
1996-05-13
|
0.34
|
1996-06-10
|
1996-02-13
|
0.34
|
1996-03-11
|
1995-11-13
|
0.69
|
1995-12-11
|
1995-08-11
|
0.64
|
1995-09-11
|
1995-05-09
|
0.64
|
1995-06-12
|
1995-02-09
|
0.64
|
1995-03-10
|
1994-11-08
|
0.63
|
1994-12-12
|
1994-08-09
|
0.63
|
1994-09-12
|
1994-05-09
|
0.63
|
1994-06-10
|
1994-02-09
|
0.63
|
1994-03-10
|
1993-11-08
|
0.61
|
1993-12-10
|
1993-08-09
|
0.61
|
1993-09-10
|
1993-05-10
|
0.61
|
1993-06-10
|
1993-02-09
|
0.61
|
1993-03-10
|
1992-11-06
|
0.55
|
1992-12-10
|
1992-08-10
|
0.55
|
1992-09-10
|
1992-05-11
|
0.55
|
1992-06-10
|
1992-02-10
|
0.55
|
1992-03-10
|
1991-11-08
|
0.50
|
1991-12-10
|
1991-08-09
|
0.50
|
1991-09-10
|
1991-05-09
|
0.50
|
1991-06-08
|
1991-02-07
|
0.50
|
1991-03-09
|
1990-11-08
|
0.41
|
1990-12-08
|
1990-08-09
|
0.41
|
1990-09-08
|
1990-05-09
|
0.41
|
1990-06-09
|
1990-02-09
|
0.41
|
1990-03-10
|
1989-11-09
|
0.34
|
1989-12-09
|
1989-08-09
|
0.34
|
1989-09-09
|
1989-05-09
|
0.34
|
1989-06-10
|
1989-02-09
|
0.68
|
1989-03-10
|
1988-11-08
|
0.57
|
1988-12-10
|
1988-08-09
|
0.57
|
1988-09-10
|
1988-05-09
|
0.57
|
1988-06-10
|
1988-02-09
|
0.57
|
1988-03-10
|
1987-11-06
|
0.50
|
1987-12-10
|
1987-08-10
|
0.50
|
1987-09-10
|
1987-05-11
|
0.50
|
1987-06-10
|
1987-02-09
|
0.50
|
1987-03-10
|
1986-11-07
|
0.45
|
1986-12-10
|
1986-08-11
|
0.45
|
1986-09-10
|
1986-05-09
|
0.45
|
1986-06-10
|
1986-02-07
|
0.45
|
1986-03-08
|
1985-11-08
|
0.80
|
1985-12-10
|
1985-08-09
|
0.80
|
1985-09-10
|
1985-05-09
|
0.80
|
1985-06-08
|
1985-02-08
|
0.80
|
1985-03-09
|
1984-11-08
|
0.80
|
1984-12-08
|
1984-08-09
|
0.73
|
1984-09-08
|
1984-05-09
|
0.73
|
1984-06-09
|
1984-02-08
|
0.73
|
1984-03-10
|
1983-11-07
|
0.73
|
1983-12-10
|
1983-08-09
|
0.73
|
1983-09-10
|
1983-05-09
|
0.65
|
1983-06-10
|
1983-02-09
|
0.68
|
1983-03-10
|
1982-11-05
|
0.65
|
1982-12-10
|
1982-08-09
|
0.65
|
1982-09-10
|
1982-05-10
|
0.65
|
1982-06-10
|
1982-02-08
|
0.65
|
1982-03-10
|
1981-11-06
|
0.08
|
1982-01-05
|
1981-08-10
|
0.57
|
1981-09-10
|
1981-05-11
|
0.57
|
1981-06-10
|
1981-02-06
|
0.57
|
1981-03-10
|
1980-11-07
|
0.57
|
1980-12-10
|
1980-08-11
|
0.57
|
1980-09-10
|
1980-05-12
|
0.52
|
1980-06-10
|
1980-02-08
|
0.52
|
1980-03-07
|
1979-11-02
|
0.52
|
1979-12-08
|
1979-08-06
|
0.52
|
1979-09-08
|
1979-05-07
|
0.45
|
1979-06-09
|
1979-02-05
|
0.45
|
1979-03-10
|
1978-11-03
|
0.45
|
1978-12-09
|
1978-08-07
|
0.40
|
1978-09-09
|
1978-05-08
|
0.40
|
1978-06-10
|
1978-02-06
|
0.40
|
1978-03-10
|
1977-11-03
|
0.35
|
1977-12-10
|
1977-08-08
|
0.35
|
1977-09-10
|
1977-05-09
|
0.35
|
1977-06-10
|
1977-02-04
|
0.35
|
1977-03-10
|
